ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2,609 Cr | ₹521 Cr | ₹283 Cr | ₹235 Cr | ₹220 Cr |
What is the latest Total Current Liabilities ratio of ERIS LIFESCIENCES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹2,609 Cr |
Mar2023 | ₹521 Cr |
Mar2022 | ₹283 Cr |
Mar2021 | ₹235 Cr |
Mar2020 | ₹220 Cr |
How is Total Current Liabilities of ERIS LIFESCIENCES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,609 Cr | 400.58 | |
Mar2023 | ₹521 Cr | 83.94 | |
Mar2022 | ₹283 Cr | 20.34 | |
Mar2021 | ₹235 Cr | 6.94 | |
Mar2020 | ₹220 Cr | - |
Compare Total Current Liabilities of peers of ERIS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ERIS LIFESCIENCES | ₹20,097.9 Cr | 18.3% | 14.7% | 61% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
ERIS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ERIS LIFESCIENCES | 18.3% |
14.7% |
61% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses